CGKD Home | ANU Home | Search ANU
The Australian National University
Centre for Governance of Knowledge and Development (CGKD)
Regulatory Institutions Network
Printer Friendly Version of this Document

Associates

 

Professor David Henry, University of Newcastle

Mr Zein Kebonang, University of Botswana

Mr Gary Lea, Australian Defence Force Academy, University of New South Wales

Ms Brita Pekarsky, University of South Australia

Dr Luigi Palombi, University of New South Wales

Professor Clifford Shearing, The Australian National University

Professor William van Caenegem, Bond University

Thom van Dooren, The Australian National University

Dr Matthew Rimmer, The Australian National Unviersity

 

 

 

 

 

 

Professor David Henry

Professor David Henry is an authority on cost effectiveness in drug selection processes. He was a member of the Pharmaceutical Benefits Advisory Committee (PBAC) and chair of the Economics Sub-committee of PBAC 1993-2001. As a member of the group responsible for the background research prior to implementation of the cost-effectiveness requirements for listing of drugs on the Australian PBS he assisted in establishing the PBS evaluation process now in use. David has worked with the World Health Organisation and has expertise in international systems for pricing of therapeutic drugs. He has delivered invited national and international presentations on access to medicines and drug pricing issues and has conducted drug policy issues courses for the WHO, Boston University and AusAid. During the last decade, in addition to his academic commitments, he has worked continuously as an internal medicine specialist and clinical toxicologist in the Newcastle region. He is chair of the Medical Staff Council at the Mater Hospital in Newcastle, New South Wales.

David is currently working collaboratively with the ANU’s Professor Peter Drahos and Dr Thomas Faunce in CGKD on a three-year research project funded by the Australian Research Council and the ANU to investigate the impact of international trade agreements - including the recent US-Australia Free Trade Agreement - on the regulation of and access to medicines in Australia.

top

Dr Zein Kebonang

Zein Kebonang is a law lecturer at the University of Botswana where he teaches Taxation, Company Law, Administrative Law, Legal Ethics and Contract. He obtained his Law (LLB) degree at the University of Botswana, his masters degree (LLM/ITP) at Harvard Law School and has submitted his thesis for a doctorate (PhD) at the ANU. He has taught comparative tax administration at the Southern African Tax Institute, University of Pretoria and has been a visiting Research Fellow with the International Tax Program at Harvard Law School. His research interests are varied and he has published extensively in reputable journals. He his currently researching on the relationship between leadership and foreign direct investment.

Click here to view Zein's publications

top



Mr Gary Lea

Gary Lea is currently Senior Lecturer in Business Law at ADFA, the University of New South Wales, based in Canberra, where he is responsible for all undergraduate and postgraduate business law teaching in the School of Business.

Gary was Senior Research Fellow and Lecturer in IP Law, Queen Mary, University of London (1998–2004) and held the Herchel Smith Junior Research Fellowship, Queen Mary, University of London (1997–1998). He worked as a Trademark Assistant at Haseltine Lake, Bristol (1996–1997) and prior to this was a Lecturer in Law at the University of Reading (1994–1996).

Gary's draft paper 'Patent and Antitrust Problems Revisited in the Context of Wireless Networking' is now available. Comments welcome to g.lea@adfa.edu.au

top


Ms Brita Pekarsky

Brita Pekarsky is a Senior Research Fellow at the Centre for Regulation and Market Analysis at the University of South Australia. Her research interests are the regulation of the pharmaceutical industry, health technology assessment and financing of primary health care in Australia, particularly for marginalised communities and individuals. She is currently developing alternative methods to price pharmaceuticals purchased by the PBS.

Brita is an experienced analyst of the Australian health care system. She was a member of the National evaluation team for the Coordinated Care Trials (which went for 4 years from 1997 to 2000)and had responsibility for the financial, economic and quantitative analyses and the evaluation framework. In the last 10 years she has worked on more than 40 consultancies in the area of health care evaluation, both as an academic and as a consultant with KPMG Consulting (1997 to 2000).

Brita has been a member of the Economic Subcommittee of the PBAC since May 1997 and has played a primary role in the development of the requirements for economic evaluation of pharmaceuticals for PBAC submissions.

top

 

Dr Luigi Palombi

Dr Luigi Palombi is an expert on biotechnology patents in Australia, the European Union and the United States of America. Luigi holds degrees in law and economics from the University of Adelaide and earned his PhD (The Patenting of Biological Materials in the Context of the Agreement on Trade Related Aspects of Intellectual Property) from the University of New South Wales. He has been a barrister and solicitor since 1982 and has specialised in intellectual property law since 1986.

Having consulted for biotechnology companies around the world, he has played an important role in achieving greater public availability to the hepatitis C virus (HCV) genome, which during the 1990s was tightly controlled by Chiron Corp, the patent owner of isolated HCV genetic sequences and proteins. Since the early 90s he has focused his professional efforts on reducing the negative impact of patents over isolated genetic sequences on medical and scientific research. His work has led him to the development of a sui generis alternative to the patent system for biotechnological innovations and his present research is directed to the full development of what he calls the Genetic Sequence Right.

In September 2005 he participated in a conference on Open Sourcing in Biotechnology held in Bellagio, Italy, at the invitation of the Rockefeller Foundation. The Queen Mary Intellectual Property Research Institute has invited him to speak on Genetic Sequence Right at an international conference being held in London in December 2005.

Luigi was invited to present at the 11th International Congress of Human Genetics held in Brisbane in August 2006. In November 2006, he was invited to present to the European Society of Human Genetics in Leuven, Belgium on the impact of patenting on human genetic research and the Genetic Sequence Right.

Luigi has produced an Explanatory Memorandum to explain the rationale behind the need for a Genetic Sequence Right.

Luigi is project director of the Genetic Sequence Right Project.

View publications

top

Professor Clifford Shearing

Clifford Shearing is engaged in projects that relate security, broadly understood, to knowledge and development in Australia, Argentina, Brazil, Northern Ireland and South Africa. His recent publications include Governing Security: Explorations in Policing and Justice (with Les Johnston--Routledge , 2003) and Imagining Security (with Jennifer Wood, Willan, 2006, forthcoming).

View publications

top

 

Professor William van Caenegem

Professor William van Caenegem teaches at the Law Faculty of Bond University, Queensland. His main area of research is intellectual property policy, in particular in relation to the impact of all areas of IP law on innovation. He has undertaken comparative research in a number of fields, including intellectual property and criminal procedure. The relationship between intellectual property and development is a central theme in his post-graduate teaching.

He has published works on domestic intellectual property law, as well as trade marks law and competition, copyright in the digital environment, patent scope, and innovation policy. The impact of international treaty negotiations on the national development of intellectual property structures, both in Australia and in neighbouring countries is studied in some of his recent publications, inter alia in the context of the regulation of geographical indications of origin.

top

 

Mr Thom van Dooren

Thom van Dooren is a PhD student in the Centre for Resource and Environmental Studies at the ANU. His background is in philosophy and religious studies, and at present he is conducting interdisciplinary research on people's relationships with agricultural seed. In particular, he is interested in the philosophical underpinnings of the various systems of control and ownership through which these relationships are mediated in the modern world.

top

 

Dr Matthew Rimmer

Dr Matthew Rimmer is a senior lecturer and the director of Higher Degree Research at the ANU College of Law. He holds a BA (Hons) and a University Medal in literature, and a LLB (Hons) from the Australian National University, and a PhD in law from the University of New South
Wales. Rimmer is an associate director of ACIPA, a member of the Copyright and Intellectual Property Advisory Group of the Australian Library and Information Association, and a director of the Australian Digital Alliance.

Rimmer wrote his dissertation on "The Pirate Bazaar: The Social Life of Copyright Law". He has published widely on copyright law - addressing such topics as copyright term extension, fair use and time-shifting, iPods and TiVo, search engines like Google, peer to peer networks such
as Napster and Kazaa, moral rights, and traditional knowledge. Rimmer also participated in policy debates over Film Directors' copyright, the Digital Agenda Act, and the Australia-United States Free Trade Agreement. He is currently writing a monograph on digital copyright and
the consumer revolution. Rimmer is a member of the group of investigators in the ARC Linkage Project, "Unlocking IP" (2005-2008).

Rimmer was a chief investigator in an ARC Discovery Project, "Gene Patents In Australia: Options For Reform" (2003-2005). He has published a number of articles on gene patents, and their impact on research, health-care, and competition. His work considers how the law
accommodates new frontier technologies - such as genomics, proteomics, bioinformatics, stem cell research, and nanotechnology. Rimmer is currently writing a monograph on intellectual property and biotechnology.

Rimmer was a chief investigator on an ARC Linkage Project, "The Protection of Botanical Inventions" (2003). He is an authority on plant breeders' rights, agricultural patents, technology use agreements, and genetic use restriction technologies. He is also an expert on issues
surrounding access to genetic resources, informed consent, and benefit-sharing.


top